CBRE vs DOC
CBRE Group vs Healthpeak Properties — AI-powered side-by-side comparison
VS
DOC
Healthpeak Properties
64
Buy
| Metric | CBRE | DOC |
|---|
| AI Score |
69
|
64
|
| Price |
$147.42
|
$20.50
|
| P/E Ratio |
33.60×
|
58.60×
|
| ROE |
13.0%
|
1.0%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
17.7%
|
2.5%
|
| Debt / Equity |
1.26×
|
1.32×
|
| Dividend Yield |
0.0%
|
5.9%
|
| RSI (14) |
43.8
|
31.1
|
| Beta |
1.193
|
0.991
|
| Expected Upside |
+2.4%
|
+1.6%
|
AI Committee View
Current Innellis committee reasoning for CBRE versus DOC.
CBRE leads by 5 points.
CBRE scores 69/100 (Buy) versus DOC at 64/100 (Buy).
CBRE Committee View
75% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical
DOC Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical
- Price trading below the lower Bollinger Band -- stretched to the downside — Technical